In the latest trading session,, 0.68 million Viking Therapeutics Inc (NASDAQ:VKTX) shares changed hands as the company’s beta touched 0.65. With the company’s most recent per share price at $27.12 changed hands at -$1.31 or -4.60% at last look, the market valuation stands at $3.05B. VKTX’s current price is a discount, trading about -201.36% off its 52-week high of $81.73. The share price had its 52-week low at $18.92, which suggests the last value was 30.24% up since then.
Analysts gave the Viking Therapeutics Inc (VKTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.21. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 0 recommended VKTX as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Instantly VKTX was in red as seen in intraday trades today. With action -4.16%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -32.60%, with the 5-day performance at -4.16% in the red. However, in the 30-day time frame, Viking Therapeutics Inc (NASDAQ:VKTX) is 13.30% up.
The consensus price target for the stock as assigned by Wall Street analysts is 74.5, meaning bulls need an upside of 63.6% from its recent market value. According to analyst projections, VKTX’s forecast low is 74 with 75 as the target high. To hit the forecast high, the stock’s price needs a -176.55% plunge from its current level, while the stock would need to soar -172.86% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.00%. The 2025 estimates are for Viking Therapeutics Inc earnings to decrease by -86.48%.
VKTX Dividends
Viking Therapeutics Inc is expected to release its next quarterly earnings report in June.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.147% or 10.1 million shares worth $535.26 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund . With 3.3 shares estimated at $89.67 million under it, the former controlled 2.94% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund held about 2.40% of the shares, roughly 2.7 shares worth around $73.21 million.
